Stockreport

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ann [Read more]